Candriam SCA’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.73M | Buy |
+154,103
| New | +$6.73M | 0.04% | 308 |
|
|
2024
Q4 | – | Sell |
-95,821
| Closed | -$4.54M | – | 694 |
|
|
2024
Q3 | $4.54M | Sell |
95,821
-142,344
| -60% | -$6.74M | 0.03% | 377 |
|
|
2024
Q2 | $7.11M | Sell |
238,165
-90,137
| -27% | -$2.69M | 0.04% | 294 |
|
|
2024
Q1 | $13.2M | Sell |
328,302
-15,000
| -4% | -$603K | 0.08% | 222 |
|
|
2023
Q4 | $8.74M | Sell |
343,302
-145,004
| -30% | -$3.69M | 0.06% | 268 |
|
|
2023
Q3 | $6.79M | Hold |
488,306
| – | – | 0.05% | 273 |
|
|
2023
Q2 | $11.2M | Sell |
488,306
-23,170
| -5% | -$533K | 0.08% | 234 |
|
|
2023
Q1 | $13.9M | Hold |
511,476
| – | – | 0.1% | 212 |
|
|
2022
Q4 | $12.8M | Sell |
511,476
-38,142
| -7% | -$952K | 0.09% | 225 |
|
|
2022
Q3 | $12M | Buy |
549,618
+79,758
| +17% | +$1.74M | 0.08% | 232 |
|
|
2022
Q2 | $9.25M | Buy |
469,860
+55,147
| +13% | +$1.09M | 0.08% | 236 |
|
|
2022
Q1 | $17.6M | Buy |
414,713
+11,894
| +3% | +$503K | 0.12% | 185 |
|
|
2021
Q4 | $25.6M | Buy |
402,819
+7,828
| +2% | +$497K | 0.16% | 147 |
|
|
2021
Q3 | $23.2M | Sell |
394,991
-16,000
| -4% | -$940K | 0.16% | 151 |
|
|
2021
Q2 | $19.9M | Buy |
410,991
+410,984
| +5,871,200% | +$19.9M | 0.14% | 176 |
|
|
2021
Q1 | $0 | Buy |
+7
| New | – | ﹤0.01% | 810 |
|